Thursday, 26 July 2007

Outgoing AstraZeneca CFO fully backs MedImmune buy

(Reuters) - A number of analysts and investors have criticised the
acquisition, arguing AstraZeneca over-paid.




Read more at Reuters.com Mergers News
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)